{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Quoin Pharmaceuticals, Ltd."},"Symbol":{"label":"Symbol","value":"QNRX"},"Address":{"label":"Address","value":"42127 PLEASANT FOREST COURT, ASHBURN, Virginia, 20148-7349, United States"},"Phone":{"label":"Phone","value":"+1 703 980-4182"},"Industry":{"label":"Industry","value":"Medical/Dental Instruments"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Middle East"},"CompanyDescription":{"label":"Company Description","value":"Quoin Pharmaceuticals Ltd is a pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others."},"CompanyUrl":{"label":"Company Url","value":"https://www.quoinpharma.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Denise Carter","title":"Chief Operating Officer & Director"},{"name":"Michael Myers","title":"Chairman & Chief Executive Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}